{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T01:44:12Z","timestamp":1785721452318,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007765","name":"Shenyang Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["202054071"],"award-info":[{"award-number":["202054071"]}],"id":[{"id":"10.13039\/501100007765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"DOI":"10.1186\/s12868-025-00956-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:20:27Z","timestamp":1751358027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Shikonin inhibits epithelial-mesenchymal transition in glioblastoma cells by upregulating p53 and promoting miR-361-5p level to suppress ZEB1 expression"],"prefix":"10.1186","volume":"26","author":[{"given":"Fengying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixue","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"2","key":"956_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/nan.12432","volume":"44","author":"P Wesseling","year":"2018","unstructured":"Wesseling P, Capper D. WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol. 2018;44(2):139\u201350. https:\/\/doi.org\/10.1111\/nan.12432.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"956_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/14728222.2020.1762568","volume":"24 7","author":"M Muir","year":"2020","unstructured":"Muir M, Gopakumar S, Traylor J, Lee S, Rao G. Glioblastoma multiforme: novel therapeutic targets. Expert Opin Ther Targets. 2020;24 7:605\u201314. https:\/\/doi.org\/10.1080\/14728222.2020.1762568.","journal-title":"Expert Opin Ther Targets"},{"key":"956_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.addr.2021.01.012","volume":"171","author":"TI Janjua","year":"2021","unstructured":"Janjua TI, Rewatkar P, Ahmed-Cox A, Saeed I, Mansfeld FM, Kulshreshtha R, et al. Frontiers in the treatment of glioblastoma: past, present and emerging. Adv Drug Deliv Rev. 2021;171:108\u201338. https:\/\/doi.org\/10.1016\/j.addr.2021.01.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"956_CR4","first-page":"1273","volume":"68 8","author":"FA Hashmi","year":"2018","unstructured":"Hashmi FA, Salim A, Shamim MS, Bari ME. Biological characteristics and outcomes of gliosarcoma. J Pak Med Assoc. 2018;68 8:1273\u20135.","journal-title":"J Pak Med Assoc"},{"key":"956_CR5","doi-asserted-by":"publisher","unstructured":"Colella B, Faienza F, Di Bartolomeo S. EMT regulation by autophagy: A new perspective in glioblastoma biology. Cancers (Basel). 2019;11(3). https:\/\/doi.org\/10.3390\/cancers11030312.","DOI":"10.3390\/cancers11030312"},{"key":"956_CR6","doi-asserted-by":"publisher","first-page":"104463","DOI":"10.1016\/j.phrs.2019.104463","volume":"149","author":"C Guo","year":"2019","unstructured":"Guo C, He J, Song X, Tan L, Wang M, Jiang P, et al. Pharmacological properties and derivatives of shikonin-A review in recent years. Pharmacol Res. 2019;149:104463. https:\/\/doi.org\/10.1016\/j.phrs.2019.104463.","journal-title":"Pharmacol Res"},{"key":"956_CR7","doi-asserted-by":"publisher","first-page":"935894","DOI":"10.3389\/fchem.2022.935894","volume":"10","author":"LN Ke","year":"2022","unstructured":"Ke LN, Kong LQ, Xu HH, Chen QH, Dong Y, Li B, et al. Research progress on structure and Anti-Gynecological malignant tumor of Shikonin. Front Chem. 2022;10:935894. https:\/\/doi.org\/10.3389\/fchem.2022.935894.","journal-title":"Front Chem"},{"key":"956_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.fitote.2019.03.005","volume":"134","author":"F Wang","year":"2019","unstructured":"Wang F, Yao X, Zhang Y, Tang J. Synthesis, biological function and evaluation of Shikonin in cancer therapy. Fitoterapia. 2019;134:329\u201339. https:\/\/doi.org\/10.1016\/j.fitote.2019.03.005.","journal-title":"Fitoterapia"},{"key":"956_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1389557517666170228114809","volume":"18 2","author":"X Zhang","year":"2018","unstructured":"Zhang X, Cui JH, Meng QQ, Li SS, Zhou W, Xiao S. Advance in Anti-tumor mechanisms of Shikonin, Alkannin and their derivatives. Mini Rev Med Chem. 2018;18 2:164\u201372. https:\/\/doi.org\/10.2174\/1389557517666170228114809.","journal-title":"Mini Rev Med Chem"},{"key":"956_CR10","doi-asserted-by":"publisher","first-page":"153805","DOI":"10.1016\/j.phymed.2021.153805","volume":"94","author":"Q Sun","year":"2022","unstructured":"Sun Q, Gong T, Liu M, Ren S, Yang H, Zeng S, et al. Shikonin, a naphthalene ingredient: therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches. Phytomedicine. 2022;94:153805. https:\/\/doi.org\/10.1016\/j.phymed.2021.153805.","journal-title":"Phytomedicine"},{"key":"956_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms231911502","volume":"23","author":"A Menon","year":"2022","unstructured":"Menon A, Abd-Aziz N, Khalid K, Poh CL, Naidu R. MiRNA: A promising therapeutic target in Cancer. Int J Mol Sci. 2022;23:19. https:\/\/doi.org\/10.3390\/ijms231911502.","journal-title":"Int J Mol Sci"},{"key":"956_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2147\/dddt.S236216","volume":"14","author":"Q Tang","year":"2020","unstructured":"Tang Q, Liu L, Zhang H, Xiao J, Hann SS. Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal transition in cervical Cancer cells. Drug Des Devel Ther. 2020;14:577\u201389. https:\/\/doi.org\/10.2147\/dddt.S236216.","journal-title":"Drug Des Devel Ther"},{"key":"956_CR13","doi-asserted-by":"publisher","first-page":"766165","DOI":"10.3389\/fphar.2021.766165","volume":"12","author":"J Pan","year":"2021","unstructured":"Pan J, Li M, Yu F, Zhu F, Wang L, Ning D, et al. Up-Regulation of p53\/miR-628-3p pathway, a novel mechanism of Shikonin on inhibiting proliferation and inducing apoptosis of A549 and PC-9 Non-Small cell lung Cancer cell lines. Front Pharmacol. 2021;12:766165. https:\/\/doi.org\/10.3389\/fphar.2021.766165.","journal-title":"Front Pharmacol"},{"key":"956_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.7150\/jca.47553","volume":"12 1","author":"C Bao","year":"2021","unstructured":"Bao C, Liu T, Qian L, Xiao C, Zhou X, Ai H, et al. Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p\/PTEN\/Akt pathway. J Cancer. 2021;12 1:76\u201388. https:\/\/doi.org\/10.7150\/jca.47553.","journal-title":"J Cancer"},{"issue":"2","key":"956_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/cbin.11247","volume":"44","author":"X Li","year":"2020","unstructured":"Li X, Zeng X. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b\/SMAD7\/TGF-\u03b2 signaling pathway. Cell Biol Int. 2020;44(2):467\u201376. https:\/\/doi.org\/10.1002\/cbin.11247.","journal-title":"Cell Biol Int"},{"issue":"1\u20132","key":"956_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbrc.2015.10.153","volume":"468","author":"J Liu","year":"2015","unstructured":"Liu J, Qu CB, Xue YX, Li Z, Wang P, Liu YH. MiR-143 enhances the antitumor activity of Shikonin by targeting BAG3 expression in human glioblastoma stem cells. Biochem Biophys Res Commun. 2015;468(1\u20132):105\u201312. https:\/\/doi.org\/10.1016\/j.bbrc.2015.10.153.","journal-title":"Biochem Biophys Res Commun"},{"key":"956_CR17","doi-asserted-by":"publisher","first-page":"6561047","DOI":"10.1155\/2022\/6561047","volume":"2022","author":"C Ke","year":"2022","unstructured":"Ke C, Shen M, Wang P, Chen Z, Lin S, Dong F. ALDH1A3-Linc00284 Axis mediates the invasion of colorectal Cancer by targeting TGF\u03b2 signaling via sponging miR-361-5p. Int J Genomics. 2022;2022:6561047. https:\/\/doi.org\/10.1155\/2022\/6561047.","journal-title":"Int J Genomics"},{"issue":"2","key":"956_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/cad.0000000000000846","volume":"31","author":"B Qian","year":"2020","unstructured":"Qian B, Zhang D, Tao R, Yu G, Jia B, Ye K, et al. MiR-361-5p exerts tumor-suppressing functions in gastric carcinoma by targeting syndecan-binding protein. Anticancer Drugs. 2020;31(2):131\u201340. https:\/\/doi.org\/10.1097\/cad.0000000000000846.","journal-title":"Anticancer Drugs"},{"key":"956_CR19","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3892\/or.2017.5852","volume":"38 3","author":"Z Ling","year":"2017","unstructured":"Ling Z, Liu D, Zhang G, Liang Q, Xiang P, Xu Y, et al. miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer. Oncol Rep. 2017;38 3:1621\u20138. https:\/\/doi.org\/10.3892\/or.2017.5852.","journal-title":"Oncol Rep"},{"key":"956_CR20","doi-asserted-by":"publisher","unstructured":"Hou XW, Sun X, Yu Y, Zhao HM, Yang ZJ, Wang X et al. miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1. Neoplasma. 2017;64 4:526\u2013\u200934; https:\/\/doi.org\/10.4149\/neo_2017_406.","DOI":"10.4149\/neo_2017_406"},{"key":"956_CR21","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3892\/or.2017.5406","volume":"37 3","author":"X Zhang","year":"2017","unstructured":"Zhang X, Wei C, Li J, Liu J, Qu J. MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1. Oncol Rep. 2017;37 3:1849\u201356. https:\/\/doi.org\/10.3892\/or.2017.5406.","journal-title":"Oncol Rep"},{"key":"956_CR22","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.2147\/ott.S171539","volume":"11","author":"J Liu","year":"2018","unstructured":"Liu J, Yang J, Yu L, Rao C, Wang Q, Sun C, et al. miR-361-5p inhibits glioma migration and invasion by targeting SND1. Onco Targets Ther. 2018;11:5239\u201352. https:\/\/doi.org\/10.2147\/ott.S171539.","journal-title":"Onco Targets Ther"},{"key":"956_CR23","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1021\/acs.jnatprod.2c00457","volume":"85 10","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Y, Li Y, Kou X, Xue Z. Mechanisms of Biochanin A alleviating PM2.5 organic Extracts-Induced EMT of A549 cells through the PI3K\/Akt pathway. J Nat Prod. 2022;85 10:2290\u2013301. https:\/\/doi.org\/10.1021\/acs.jnatprod.2c00457.","journal-title":"J Nat Prod"},{"key":"956_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13020-020-00305-1","volume":"15","author":"HY Lin","year":"2020","unstructured":"Lin HY, Han HW, Wang YS, He DL, Sun WX, Feng L, et al. Shikonin and 4-hydroxytamoxifen synergistically inhibit the proliferation of breast cancer cells through activating apoptosis signaling pathway in vitro and in vivo. Chin Med. 2020;15:23. https:\/\/doi.org\/10.1186\/s13020-020-00305-1.","journal-title":"Chin Med"},{"key":"956_CR25","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3892\/or.2020.7683","volume":"44 3","author":"T Pan","year":"2020","unstructured":"Pan T, Zhang F, Li F, Gao X, Li Z, Li X, et al. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL\u20136\/STAT3 signaling pathway. Oncol Rep. 2020;44 3:1049\u201363. https:\/\/doi.org\/10.3892\/or.2020.7683.","journal-title":"Oncol Rep"},{"key":"956_CR26","doi-asserted-by":"publisher","unstructured":"Shi W, Men L, Pi X, Jiang T, Peng D, Huo S, et al. Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL\u20136\/STAT3 signaling pathway. Int J Oncol. 2021;59(6). https:\/\/doi.org\/10.3892\/ijo.2021.5279.","DOI":"10.3892\/ijo.2021.5279"},{"key":"956_CR27","doi-asserted-by":"publisher","first-page":"5386050","DOI":"10.1155\/2021\/5386050","volume":"2021","author":"J Huang","year":"2021","unstructured":"Huang J, Zhao L, Gong C, Wang Y, Qu Y, Ji C, et al. Shikonin promotes apoptosis and attenuates migration and invasion of human esophageal Cancer cells by inhibiting tumor necrosis factor Receptor-Associated protein 1 expression and AKT\/mTOR signaling pathway. Evid Based Complement Alternat Med. 2021;2021:5386050. https:\/\/doi.org\/10.1155\/2021\/5386050.","journal-title":"Evid Based Complement Alternat Med"},{"key":"956_CR28","doi-asserted-by":"publisher","unstructured":"Chen CH, Lin ML, Ong PL, Yang JT. Novel multiple apoptotic mechanism of Shikonin in human glioma cells. Ann Surg Oncol. 2012;19. https:\/\/doi.org\/10.1245\/s10434-012-2324-4. 9:3097\u2013\u2009106; doi:.","DOI":"10.1245\/s10434-012-2324-4"},{"key":"956_CR29","doi-asserted-by":"publisher","first-page":"e66326","DOI":"10.1371\/journal.pone.0066326","volume":"8 6","author":"C Huang","year":"2013","unstructured":"Huang C, Luo Y, Zhao J, Yang F, Zhao H, Fan W, et al. Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS ONE. 2013;8 6:e66326. https:\/\/doi.org\/10.1371\/journal.pone.0066326.","journal-title":"PLoS ONE"},{"key":"956_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.canlet.2017.01.004","volume":"390","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Lu B, Wang C, Wang Z, Luo T, Piao M, et al. RIP1 and RIP3 contribute to shikonin-induced DNA double-strand breaks in glioma cells via increase of intracellular reactive oxygen species. Cancer Lett. 2017;390:77\u201390. https:\/\/doi.org\/10.1016\/j.canlet.2017.01.004.","journal-title":"Cancer Lett"},{"key":"956_CR31","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/aps.2017.112","volume":"38 11","author":"B Lu","year":"2017","unstructured":"Lu B, Gong X, Wang ZQ, Ding Y, Wang C, Luo TF, et al. Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1\/RIP3 necrosome formation. Acta Pharmacol Sin. 2017;38 11:1543\u201353. https:\/\/doi.org\/10.1038\/aps.2017.112.","journal-title":"Acta Pharmacol Sin"},{"key":"956_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2018.03.046","volume":"425","author":"B Lu","year":"2018","unstructured":"Lu B, Wang Z, Ding Y, Wang X, Lu S, Wang C, et al. RIP1 and RIP3 contribute to shikonin-induced Glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide. Cancer Lett. 2018;425:31\u201342. https:\/\/doi.org\/10.1016\/j.canlet.2018.03.046.","journal-title":"Cancer Lett"},{"key":"956_CR33","doi-asserted-by":"publisher","first-page":"e81815","DOI":"10.1371\/journal.pone.0081815","volume":"8 11","author":"FL Zhang","year":"2013","unstructured":"Zhang FL, Wang P, Liu YH, Liu LB, Liu XB, Li Z, et al. Topoisomerase I inhibitors, Shikonin and Topotecan, inhibit growth and induce apoptosis of glioma cells and glioma stem cells. PLoS ONE. 2013;8 11:e81815. https:\/\/doi.org\/10.1371\/journal.pone.0081815.","journal-title":"PLoS ONE"},{"key":"956_CR34","doi-asserted-by":"publisher","first-page":"e94180","DOI":"10.1371\/journal.pone.0094180","volume":"9 4","author":"JT Yang","year":"2014","unstructured":"Yang JT, Li ZL, Wu JY, Lu FJ, Chen CH. An oxidative stress mechanism of Shikonin in human glioma cells. PLoS ONE. 2014;9 4:e94180. https:\/\/doi.org\/10.1371\/journal.pone.0094180.","journal-title":"PLoS ONE"},{"key":"956_CR35","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/ijc.29483","volume":"137 6","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Kretschmer N, Bauer R, Efferth T. Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib. Int J Cancer. 2015;137 6:1446\u201356. https:\/\/doi.org\/10.1002\/ijc.29483.","journal-title":"Int J Cancer"},{"key":"956_CR36","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.1089\/ars.2014.5973","volume":"23","author":"P Gupta","year":"2015","unstructured":"Gupta P, Jagavelu K, Mishra DP. Inhibition of NADPH Oxidase-4 potentiates 2-Deoxy-D-Glucose-Induced suppression of glycolysis, migration, and invasion in glioblastoma cells: role of the Akt\/HIF1\u03b1\/HK-2 signaling Axis. Antioxid Redox Signal. 2015;23:8665\u201381. https:\/\/doi.org\/10.1089\/ars.2014.5973.","journal-title":"Antioxid Redox Signal"},{"key":"956_CR37","doi-asserted-by":"publisher","first-page":"23823","DOI":"10.3390\/ijms161023823","volume":"16 10","author":"FY Zhang","year":"2015","unstructured":"Zhang FY, Hu Y, Que ZY, Wang P, Liu YH, Wang ZH, et al. Shikonin inhibits the migration and invasion of human glioblastoma cells by targeting phosphorylated \u03b2-Catenin and phosphorylated PI3K\/Akt: A potential mechanism for the Anti-Glioma efficacy of a traditional Chinese herbal medicine. Int J Mol Sci. 2015;16 10:23823\u201348. https:\/\/doi.org\/10.3390\/ijms161023823.","journal-title":"Int J Mol Sci"},{"key":"956_CR38","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.3892\/mmr.2019.10101","volume":"19 5","author":"N Guo","year":"2019","unstructured":"Guo N, Miao R, Gao X, Huang D, Hu Z, Ji N, et al. Shikonin inhibits proliferation and induces apoptosis in glioma cells via downregulation of CD147. Mol Med Rep. 2019;19 5:4335\u201343. https:\/\/doi.org\/10.3892\/mmr.2019.10101.","journal-title":"Mol Med Rep"},{"key":"956_CR39","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41419-021-04010-1","volume":"12 8","author":"J Jia","year":"2021","unstructured":"Jia J, Ouyang Z, Wang M, Ma W, Liu M, Zhang M, et al. MicroRNA-361-5p slows down gliomas development through regulating UBR5 to elevate ATMIN protein expression. Cell Death Dis. 2021;12 8:746. https:\/\/doi.org\/10.1038\/s41419-021-04010-1.","journal-title":"Cell Death Dis"},{"key":"956_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1172\/JCI148141","volume":"132","author":"A Ghosh","year":"2022","unstructured":"Ghosh A, Michels J, Mezzadra R, Venkatesh D, Dong L, Gomez R, et al. Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint Blockade. J Clin Invest. 2022;132:18. https:\/\/doi.org\/10.1172\/JCI148141.","journal-title":"J Clin Invest"},{"key":"956_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/tox.24396","volume":"40 1","author":"H Chen","year":"2025","unstructured":"Chen H, Gao S, Wang P, Xie M, Zhang H, Fan Y, et al. SRBD1 regulates the cell cycle, apoptosis, and M2 macrophage polarization via the RPL11-MDM2-p53 pathway in glioma. Environ Toxicol. 2025;40 1:66\u201378. https:\/\/doi.org\/10.1002\/tox.24396.","journal-title":"Environ Toxicol"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-025-00956-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:20:28Z","timestamp":1751358028000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-025-00956-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["956"],"URL":"https:\/\/doi.org\/10.1186\/s12868-025-00956-6","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments reported in the manuscript were approved by the Animal Experimentation Ethics Committee of China Medical University, China. All experiments were performed in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines () for the reporting of animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}